RU83876

RU83876 is an experimental small molecule belonging to the class of organic compounds known as dipeptides. It has a molecular formula of C30H35N3O9P2 and a molecular weight of approximately 643.6 g/mol[1][2][3]. RU83876 functions as an inhibitor of the proto-oncogene tyrosine-protein kinase Src (commonly referred to as Src kinase), which is involved in cellular signaling pathways that regulate proliferation and survival[5]. The compound is primarily studied in preclinical or experimental settings; no approved indications or clinical use cases are reported.

Other names

N-ACETYL-N-[1-(1,1'-BIPHENYL-4-YLMETHYL)-2-OXOAZEPAN-3-YL]-3,4-DIPHOSPHONOPHENYLALANINAMIDE(4-((2S)-2-(((3S)-1-(((1,1'-biphenyl)-4-yl)methyl)-2-oxoazepan-3-yl)carbamoyl)-2-acetamidoethyl)-2-phosphonophenyl)phosphonic acid